Pakitandaan na kung wala ka pang 18 taong gulang, hindi mo maa-access ang site na ito.
Ikaw ba ay 18 taong gulang o higit pa?
Mag-upload
Angkat
Aking Account
Mode
Mag log in
Magrehistro
PeerVoice Oncology & Haematology Video
|
Mga subscriber
Mag-subscribe
0
Mga video
Mga Playlist
Nagustuhan ang mga video
Tungkol sa
Pinakabagong mga video
19:42
Donna E. Reece, MD - Cases in Relapsed Refractory Multiple Myeloma: The Role of Anti-CD38–Based Regimens in an Evolving Canadian Landscape
PeerVoice Oncology & Haematology Video
1 Mga view
·
2 taon kanina
18:38
Gilles Salles, MD, PhD - Differentiating Decisions in Transplant-Ineligible Relapsed/Refractory DLBCL: What Are Our Options, and How Do We Choose Between Them?
PeerVoice Oncology & Haematology Video
1 Mga view
·
2 taon kanina
20:33
Anna Tinker, MD, FRCPC - Maximizing Survival in Advanced or Recurrent Endometrial Cancer: The Evolving Role of Immunotherapy
PeerVoice Oncology & Haematology Video
0 Mga view
·
2 taon kanina
25:15
Amit Singal, MD, MS - Recognising the Rationale and Understanding the Outcomes for CTLA-4 Targeted Therapies in Advanced HCC
PeerVoice Oncology & Haematology Video
1 Mga view
·
2 taon kanina
09:31
Julie Stakiw, MD, FRCPC - Frailty Assessment and Improved Care in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients
PeerVoice Oncology & Haematology Video
2 Mga view
·
2 taon kanina
10:20
Barbara Melosky, MD, FRCPC - Narrowing the Care Gap in NSCLC With Rare EGFR Alterations: The Next Frontier in Precision Medicine
PeerVoice Oncology & Haematology Video
1 Mga view
·
2 taon kanina
10:09
Stephen Chia, MD, FRCP(C) - Keeping Abreast of the Latest Advances in HER2-Positive Metastatic Breast Cancer Treatment: Clinical Implications for the Canadian Landscape
PeerVoice Oncology & Haematology Video
1 Mga view
·
2 taon kanina
01:15:20
Arndt Vogel, MD - Modern Management of Cholangiocarcinoma: Sharing Evidence, Experience, and Expertise
PeerVoice Oncology & Haematology Video
1 Mga view
·
3 taon kanina
21:49
Javier Cortés, MD, PhD - Updates on HER3-Targeted Therapies in NSCLC and Breast Cancer
PeerVoice Oncology & Haematology Video
0 Mga view
·
3 taon kanina
08:49
Joe O'Sullivan, MD, PhD, FRCR - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses
PeerVoice Oncology & Haematology Video
0 Mga view
·
3 taon kanina
44:29
Johnny Mahlangu, MBBCH, MMed, FCPath - Redefining Balance in Hemophilia: Can We Restore Hemostasis by Inhibiting Anticoagulation?
PeerVoice Oncology & Haematology Video
3 Mga view
·
3 taon kanina
01:00:52
Kevin Harrington, PhD, FRCR, FRCP - After More Than a Decade: Can We Now Enhance Treatment of Patients With LA SCCHN?
PeerVoice Oncology & Haematology Video
2 Mga view
·
3 taon kanina
18:16
Sara A. Hurvitz, MD, FACP - Clinical Case Challenge: Implementing ADCs Into Routine mTNBC Treatment Plans
PeerVoice Oncology & Haematology Video
1 Mga view
·
3 taon kanina
55:24
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
PeerVoice Oncology & Haematology Video
0 Mga view
·
3 taon kanina
37:54
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?
PeerVoice Oncology & Haematology Video
2 Mga view
·
3 taon kanina
21:50
Mohamad Mohty, MD, PhD - Veno-Occlusive Disease: Who to Treat, How to Treat, When to Treat
PeerVoice Oncology & Haematology Video
0 Mga view
·
3 taon kanina
Magpakita ng higit pa
Bahay
Pinakabagong mga video
Trending
Mga nangungunang video
Mga Sikat na Channel
Mag-explore pa
Tulong
Pumili ng paraan ng pagbabayad
Wika
English
Arabic
Dutch
French
German
Russian
Spanish
Turkish
Hindi
Chinese
Urdu
Indonesian
Croatian
Hebrew
Bengali
Japanese
Portuguese
Italian
Persian
Swedish
Vietnamese
Danish
Filipino
Magbayad sa pamamagitan ng Wallet
Mag log in
Username
Password
Nakalimutan ang iyong password?
Tandaan ang device na ito
Mag-login gamit ang
Bago dito?
Magrehistro
Mag-sign Up!
Username
E-mail address
Password
Dapat ay hindi bababa sa 6 na character ang haba.
Dapat maglaman ng maliit na titik.
Dapat maglaman ng malaking titik.
Dapat maglaman ng numero o espesyal na karakter.
Kumpirmahin ang Password
Lalaki
Babae
Sa pamamagitan ng paggawa ng iyong account, sumasang-ayon ka sa aming
Mga Tuntunin ng Paggamit
&
Patakaran sa Privacy
Mayroon nang account?
Mag log in